Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Conduit Pharmaceuticals Inc. (CDT) had Free Cash Flow per Share of $-11.22 for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-2.41M |
|
-- |
|
-- |
|
$3.51M |
|
$-3.51M |
|
$1.11M |
|
$-2.41M |
|
$-2.41M |
|
$-2.41M |
|
$-2.41M |
|
$-2.41M |
|
$-2.41M |
|
$-3.51M |
|
$-1.91M |
|
0.87M |
|
0.87M |
|
$-1.53 |
|
$-1.53 |
|
| Balance Sheet Financials | |
$2.71M |
|
$0.04M |
|
$1.48M |
|
$4.19M |
|
$10.74M |
|
-- |
|
$0.24M |
|
$10.99M |
|
$-6.79M |
|
$-6.79M |
|
$-6.79M |
|
1.38M |
|
| Cash Flow Statement Financials | |
$-9.68M |
|
$-0.04M |
|
$6.07M |
|
$4.23M |
|
$0.55M |
|
$-3.67M |
|
$1.63M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.25 |
|
-- |
|
-- |
|
-- |
|
-1.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.73M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
35.42% |
|
35.42% |
|
-57.38% |
|
35.42% |
|
$-4.91 |
|
|
Free Cash Flow per Share |
$-11.22 |
$-11.17 |
|